Back to mobile site

Medtronic, Inc. (MDT) PT Raised to $94 at Barclays; Reiterates Overweight

May 26, 2017 7:59 AM EDT Send to a Friend
Barclays raised its price target on Medtronic, Inc. (NYSE: MDT) to $94.00 (from $92.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login